
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference PR Newswire WALTHAM, Mass., Feb. 4, 2025 WALTHAM, Mass., Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq:...
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0899 | -2.75766871166 | 3.26 | 3.47 | 2.95 | 229562 | 3.1491028 | CS |
4 | -0.0499 | -1.54968944099 | 3.22 | 3.58 | 2.95 | 194085 | 3.21933142 | CS |
12 | -35.8199 | -91.8694537061 | 38.99 | 40.37 | 2.95 | 405632 | 6.46804037 | CS |
26 | -34.0399 | -91.4805159903 | 37.21 | 53.79 | 2.95 | 234802 | 16.06165888 | CS |
52 | -13.0699 | -80.479679803 | 16.24 | 53.79 | 2.95 | 164990 | 17.63066971 | CS |
156 | -13.0699 | -80.479679803 | 16.24 | 53.79 | 2.95 | 164990 | 17.63066971 | CS |
260 | -13.0699 | -80.479679803 | 16.24 | 53.79 | 2.95 | 164990 | 17.63066971 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.